Exchange: NASDAQ·Updated 07:59 PM EST

BPTH Bio-Path Holdings Inc

$0.21
$0.4232
(66.83%)
Today
Closed $0.21
$0.0042
(2.00%)
After Hours
Reported EarningsMay 15
Mkt Cap$1.31M
Vol6.93M

About BPTH

Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1001-A, BP1002, and BP1003. The company was founded by Peter H. Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.
56

Bullish Sentiment

How do you feel about BPTH?

Advertisement|Remove ads.